Status:
COMPLETED
Treatment of Patients With Periorbital Hyperpigmentation
Lead Sponsor:
Sohag University
Conditions:
Periorbital Hypermelanosis
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Periorbital hyperpigmentation (POH) is a common condition in dermatology practice. Periorbital hyperpigmentation is defined as bilateral, round, homogeneous pigmented macules.The etiology of POH is mu...
Detailed Description
Periorbital hyperpigmentation (POH) is a common skin condition which has a great negative effect on the patient quality of life. Many factors contribute in the pathogensis of POH which lead to develop...
Eligibility Criteria
Inclusion
- Patients with Periorbital hyperpigmentation
Exclusion
- Pregnancy and lactation .
- Allergy, hypersensitivity to the formulations to be used in the study.
- Any other cutaneous or systemic disease.
- Patient who had taken any other treatment (laser, dermabrasion) on the affected region performed less than 6 months prior to the beginning of the study.
Key Trial Info
Start Date :
February 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2020
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04389788
Start Date
February 12 2020
End Date
October 21 2020
Last Update
October 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Sohag University
Sohag, Egypt, 82524